Magnetic resonance spectroscopy imaging‐directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate‐specific antigen between 4–10 ng/mL and normal digital rectal examination

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International journal of urology

• Publication date

  2014-03-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1111/iju.12258PMID 23980749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer.

  2013cited by this paper
• Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer

  2012cited by this paper
• Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.

  2012cited by this paper
• A positive magnetic resonance spectroscopic imaging with negative initial biopsy may predict future detection of prostate cancer

  2012cited by this paper
• Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection

  2011cited by this paper
• In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.

  2011cited by this paper
• Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging

  2010cited by this paper
• Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.

  2010cited by this paper
• Accuracy of MRI/MRSI‐based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy

  2010cited by this paper
• Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer.

  2009cited by this paper
• Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings

  2009cited by this paper
• Prostate specific antigen best practice statement: 2009 update.

  2009cited by this paper
• Is it time to consider a role for MRI before prostate biopsy?

  2009cited by this paper
• Potential of 1H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy

  2009cited by this paper
• Transition zone and anterior stromal prostate cancers: Zone of origin and intraprostatic patterns of spread at histopathology

  2009cited by this paper
• Prostate cancer detection: the value of performing an MRI before a biopsy

  2009cited by this paper
• Active surveillance for early‐stage prostate cancer

  2008cited by this paper
• Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.

  2008cited by this paper
• Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective

  2008cited by this paper
• A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions

  2008cited by this paper
• Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy

  2008cited by this paper
• Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature.

  2007cited by this paper
• Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population

  2007cited by this paper
• Transrectal ultrasound‐guided biopsy of prostate voxels identified as suspicious of malignancy on three‐dimensional 1H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4–10 ng/ml

  2007cited by this paper
• Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging.

  2004cited by this paper
• Screening for prostate cancer: current recommendations.

  2004cited by this paper
• Mapping of the prostate in endorectal coil-based MRI/MRSI and CT: a deformable registration and validation study.

  2004cited by this paper
• Measurement of serum PSA in benign and malignant enlargements of prostate in Indian population: Relevance of PSAD in intermediate range PSA

  2004cited by this paper
• Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues

  2003cited by this paper
• Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

  2001cited by this paper
• Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.

  2000cited by this paper
• A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy.

  2000cited by this paper
• The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial.

  2000cited by this paper
• Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer.

  1997cited by this paper
• Solvent Suppression Using Selective Echo Dephasing

  1996cited by this paper
• Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.

  1996cited by this paper
• Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

  1989cited by this paper

• Probing the Depths for Diagnostic Performance of Biparametric and Multiparametric MRI for Prostate Cancer Detection- A Meta-Analysis

  2024cites this paper
• Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate

  2023cites this paper
• Serum prostate-specific antigen trends and prostate cancer detection on follow-up in men with a prior negative biopsy: A cohort study

  2023cites this paper
• Patients With “Gray Zone” PSA Levels: Application of Prostate MRI and MRS in the Diagnosis of Prostate Cancer

  2022cites this paper
• Raised prostate-specific antigen alone may not be a true predictor in high-risk prostate cancer: A retrospective cohort analysis

  2022influential citation
• MicroRNA-106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer

  2019cites this paper
• Multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsies increase the rate of cancer detection in populations with a low incidence of prostate cancer

  2019influential citation
• Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate Cancer: a systematic review and meta-analysis

  2019cites this paper
• Magnetic resonance spectroscopy imaging in diagnosis of suspicious prostate cancer

  2019cites this paper
• Multiparametric (mp) MRI of prostate cancer.

  2018cites this paper
• Prebiopsy multiparametric MRI‐based risk score for predicting prostate cancer in biopsy‐naive men with prostate‐specific antigen between 4–10 ng/mL

  2018cites this paper
• Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.

  2018cites this paper
• What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.

  2017cites this paper
• A systematic review on multiparametric MR imaging in prostate cancer detection

  2017cites this paper
• Role of 18F-Choline PET/CT in guiding biopsy in patients with risen PSA levels and previous negative biopsy for prostate cancer.

  2017cites this paper
• Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy.

  2016cites this paper
• Clarifying the PSA grey zone: The management of patients with a borderline PSA

  2016cites this paper
• Stratification of the aggressiveness of prostate cancer using pre‐biopsy multiparametric MRI (mpMRI)

  2016cites this paper
• Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review.

  2016cites this paper
• Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists

  2015cites this paper
• Multiparametric-MRI in diagnosis of prostate cancer

  2015influential citation
• Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer

  2015cites this paper
• Editorial Comment to Magnetic resonance spectroscopy imaging‐directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate‐specific antigen between 4–10 ng/mL and normal digital rectal examination

  2014cites this paper
• Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion.

  2014cites this paper
• Prostate Cancer Awareness, Knowledge, Perception on Self-vulnerability and Uptake of Screening among Men in Nairobi County, Kenya

  2014cites this paper
• Editorial Comment to Magnetic resonance spectroscopy imaging‐directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate‐specific antigen between 4–10 ng/mL and normal digital rectal examination

  2014cites this paper